Post Marketing Safety Surveillance of Baricitinib in Three European Registries (I4V-MC-B012)

First published 17/12/2018

Last updated 31/07/2024

EU PAS number:

EUPAS25142

Study

Finalised

Download as PDF

Documents

Study protocol

Initial protocol

B012 PASS Version 1.0 Nov2018_Redacted

English (604.46 KB - PDF) View document

Study results

Study report

Study report

LY3009104 B012 NI PASS Final Study Report_ENCePP_Redacted.pdf

English (4.31 MB - PDF) View document

Other information